Suchergebnisse - "sars-cov-2"

PubPharm (1.022)

1

Clinical characteristics and outcomes of maintenance hemodialysis patients with COVID-19 during the Omicron wave of the pandemic in Beijing : a single center retrospective study

enthalten in: BMC nephrology | 2024

von Pan, Y. | Li, D. | Zhang, Z. | +4

2

Unraveling antiviral efficacy of multifunctional immunomodulatory triterpenoids against SARS-COV-2 targeting main protease and papain-like protease

enthalten in: IUBMB life | 2024

von Choudhary, S. | Nehul, S. | Singh, A. | +4

3

RT-PCR genotyping assays to identify SARS-CoV-2 variants in England in 2021 : a design and retrospective evaluation study

enthalten in: The Lancet. Microbe | 2024

von Bray, N. | Sopwith, W. | Edmunds, M. | +15

4

Overview of the different methods for RNA preparation in COVID-19 diagnosis process during the pandemic

enthalten in: Analytical biochemistry | 2024

von Shahi, F. | Rasti, M. | Moradi, M.

5

Acute and persistent symptoms of COVID-19 infection in school-aged children : a retrospective study from China

enthalten in: BMC public health | 2024

von Wang, H. | Lu, F. | Ni, X. | +5

6

IgG antibody response to SARS-CoV-2 infection and its influencing factors in lymphoma patients

enthalten in: BMC immunology | 2024

von Xie, H. | Zhang, J. | Luo, R. | +5

7

Saliva-based Proteinase K method : A rapid and reliable diagnostic tool for the detection of SARS-COV-2 in children

enthalten in: Journal of medical virology | 2024

von Kim, M. | Park, P. | Hwang, S. | +10

8

Self-managing symptoms of Long COVID : an education and strategies research protocol

enthalten in: Frontiers in public health | 2024

von Rybkina, J. | Jacob, N. | Colella, B. | +7

9

Vaccination against influenza viruses reduces infection, not hospitalization or death, from respiratory COVID-19 : A systematic review and meta-analysis

enthalten in: Journal of medical virology | 2024

von Pontiroli, A. | Scovenna, F. | Carlini, V. | +5

10

Immunogenicity and safety of Biological E's CORBEVAX™ vaccine compared to COVISHIELD™ (ChAdOx1 nCoV-19) vaccine studied in a phase-3, single blind, multicentre, randomized clinical trial

enthalten in: Human vaccines & immunotherapeutics | 2023

von Thuluva, S. | Paradkar, V. | Gunneri, S. | +19

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[103]